Regeneron Pharmaceuticals Inc. buy SVB Leerink LLC
Summary
This prediction ended on 29.03.24 with a price of €902.40. The BUY prediction by SVB_Leerink_LLC finished with a performance of 19.76%. SVB_Leerink_LLC has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Regeneron Pharmaceuticals Inc. | 0.909% | 0.909% | 32.711% |
iShares Core DAX® | 1.662% | 4.835% | 17.361% |
iShares Nasdaq 100 | 0.667% | 0.000% | 38.234% |
iShares Nikkei 225® | -2.139% | -4.786% | 13.099% |
iShares S&P 500 | 0.564% | 0.775% | 29.181% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
In the thread Trading Regeneron Pharmaceuticals Inc.